Sotagliflozin

1. Sotagliflozin decreases cardiovascular events in humans.

   Reviewtype 2 diabetes and recent worsening heart failure

   Cost-Effectiveness of Sotagliflozin in Heart Failure Patients with Preserved and Reduced Ejection Fractions - Results from SOLOIST-WHF · The American journal of cardiology · 30 Sep 2026

1. Sotagliflozin improves quality-adjusted life-years in silico (0.39 QALYs (4.43 vs. 4.04)).

   In silicodiabetes and recent worsening heart failure

   Cost-Effectiveness of Sotagliflozin in Heart Failure Patients with Preserved and Reduced Ejection Fractions - Results from SOLOIST-WHF · The American journal of cardiology · 30 Sep 2026

1. Sotagliflozin extends lifespan in silico (0.64 life-years (7.12 vs. 6.48)).

   In silicodiabetes and recent worsening heart failure

   Cost-Effectiveness of Sotagliflozin in Heart Failure Patients with Preserved and Reduced Ejection Fractions - Results from SOLOIST-WHF · The American journal of cardiology · 30 Sep 2026

1. Sotagliflozin has no effect on liver injury in humans.

   Review

   Sotagliflozin · National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda (MD) · 19 Sep 2026

Liver injury →

1. Sotagliflozin lowers the risk of heart failure in humans.

   Reviewadults with heart failure or with type 2 diabetes and chronic kidney disease

   Sotagliflozin · National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda (MD) · 19 Sep 2026

Heart failure →

1. Sotagliflozin lowers the risk of cardiovascular death in humans.

   Reviewadults with heart failure or with type 2 diabetes and chronic kidney disease

   Sotagliflozin · National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda (MD) · 19 Sep 2026